NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

SITC Abstract is supported by a number of MD Anderson Doctors, something that a large number of folks have pointed out.

One interesting thing is the support from the leadership team, Department Chair Funda Meric-Bernstam and Deputy Chair David Hong, of MD Anderson's Investigational Cancer Therapeutics. Not sure if they are signing their name on this abstract due to the AF/MD Anderson fiasco or if they are attaching their names to what they believe to be the next big step in cancer treatments.

Questions that come to my mind ...
First, I wonder why AF was not directed to the actual department managing the DCVax-Direct trial when he called MD Anderson.

But more importantly, I wonder if DCVax-Direct would be on the radar of these department leadership if AF/Shareholders did not make such a huge commotion out of those "Unsupported" PRs ...

Or if it would have drawn this many doctors to DCVax-Direct.

One thing we can be sure, whatever data that will be presented in SITC has probably been reviewed easily multiple times by probably the best Cancer minds that MD Anderson currently employ.

Just some food for thought, though no one here really needs reassurance.